DMAAR — Drugs Made In America Acquisition Corp. Rights
NASDAQ
$0.14
+$0.00 (+1.82%)
Drugs Made In America Acquisition Corp. Rights (DMAAR) common stock listed on NASDAQ. It is led by Roger Bendelac, based in 420 Lexington Avenue, New York, NY, United States, 10170. Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Net income was $2.2M. DMAAR currently screens at market cap $1.8M.
Use this DMAAR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the DMAAR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the DMAAR SEC filings page. Lician reads the product cache first so this HTML stays unique to Drugs Made In America Acquisition Corp. Rights even when a live quote feed is slow.
About Drugs Made In America Acquisition Corp. Rights
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
DMAAR Key Statistics
Market Cap
$1.83M
Volume
153,374
Previous Close
$0.14
Day Range
$0.13 – $0.14
EPS
-$0.03
Revenue
$0.00
Net Income
-$279.85K
Gross Profit
$0.00
Free Cash Flow
$0.00
DMAAR Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 |
|---|---|
| Revenue | $0.00 |
| Cost of Revenue | $0.00 |
| Gross Profit | $0.00 |
| Operating Income | $0.00 |
| Net Income | -$279.85K |
| EPS (Diluted) | -$0.03 |
Total Assets
$550.82K
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$1.35K
Operating Cash Flow
-$172.26K
Free Cash Flow
$0.00
Drugs Made In America Acquisition Corp. Rights Company Information
- Chief Executive Officer
- Roger Bendelac
- Headquarters
- 420 Lexington Avenue, New York, NY, United States, 10170
- Website
- dmaacorp.com
- Phone
- 646 726 7074
- IPO / Founded
- 2025-02-25